- Home
- YQ vs CRIS Comparison
YQ vs CRIS Comparison
Compare YQ & CRIS Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
Company Overview
Basic Information| Metric | YQ | CRIS |
|---|---|---|
| Founded | 2012 | 2000 |
| Country | China | United States |
| Employees | N/A | N/A |
| Industry | Other Consumer Services | Biotechnology: Biological Products (No Diagnostic Substances) |
| Sector | Real Estate | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 22.2M | 20.6M |
| IPO Year | 2020 | 2000 |
Fundamental Metrics
Financial Performance| Metric | YQ | CRIS |
|---|---|---|
| Price | $2.40 | $4.81 |
| Analyst Decision | | Strong Buy |
| Analyst Count | 0 | 2 |
| Target Price | N/A | ★ $17.00 |
| AVG Volume (30 Days) | 6.2K | ★ 7.6M |
| Earning Date | 06-09-2026 | 05-07-2026 |
| Dividend Yield | N/A | N/A |
| EPS Growth | N/A | ★ 91.57 |
| EPS | ★ N/A | N/A |
| Revenue | N/A | ★ $9,898,000.00 |
| Revenue This Year | N/A | $27.10 |
| Revenue Next Year | N/A | $67.74 |
| P/E Ratio | N/A | ★ N/A |
| Revenue Growth | N/A | ★ 31.50 |
| 52 Week Low | $1.70 | $0.18 |
| 52 Week High | $6.45 | $6.74 |
Technical Indicators
Market Signals| Indicator | YQ | CRIS |
|---|---|---|
| Relative Strength Index (RSI) | 52.98 | 80.18 |
| Support Level | $1.98 | $0.66 |
| Resistance Level | $2.62 | N/A |
| Average True Range (ATR) | 0.14 | 0.32 |
| MACD | 0.04 | 0.54 |
| Stochastic Oscillator | 76.52 | 73.78 |
Price Performance
Historical ComparisonAbout YQ 17 Education & Technology Group Inc.
17 Education & Technology Group Inc is engaged in providing education and education technology services in the People's Republic of China (PRC) with a focus on the Teaching and Learning SaaS offerings. It offers smart, in-school, teaching and learning SaaS offerings assist students, teachers, schoolmasters and educational authorities across China. It also offer other educational products and services that complement students' in-school learning. Geographically group operates in China.
About CRIS Curis Inc.
Curis Inc is a biotechnology company that develops and commercializes drugs and therapies in the immuno-oncology and precision oncology therapeutic areas. The company targets solid tumors, diffuse large B-cell lymphoma, solid tumors or lymphomas, hematological cancers, and others. Its pipeline products include Fimepinostat, CA-170, CA-4948, CA-327, and Erivedge.